CCL20 and nasopharyngeal carcinoma: EBV+ cHL cell lines that lacked EBNA1 expression did not have increased CCL20 expression, but cell lines that retained EBNA1, including cases of EBV+ nasopharyngeal carcinoma, had increased CCL20 expression.